NEWS
SOFIE executes order to purchase a top-of-the line GE PETtrace 890
SOFIE has placed a purchase order for GE Healthcare’s top-of-the-line PETtrace 890 dual-particle cyclotron. The machine will be installed [...]
SOFIE affiliate, iTheranostics, executes agreement for its promising library of Fibroblast Activation Protein (FAP) targeted theranostics
Novartis has acquired global development and commercial rights to therapeutic applications for iTheranostics' library of FAP-targeted drugs licensed from [...]
SOFIE Inc. enters into partnership with AUGMENTICON™
AUGMENTICON™, a privately held technology company developing Augmented-/Mixed-Reality (AR-/MR)-tools for a cost-effective, high-quality manufacturing of (radio-)pharmaceuticals, announces the formation [...]
SOFIE announces promotion of Mike Parisi to Vice President of Sales & Marketing
Mike brings nearly 25 years of Nuclear Medicine, Sales and Management experience to SOFIE. Mike has been with our [...]
SOFIE Signs Commercial Supply Agreement with Lantheus Holdings, Inc. to Manufacture PyL™
SOFIE, an established Radiopharmaceutical Contract Manufacturing Organization and GMP radiopharmacy network, has signed a commercial supply agreement with Lantheus [...]
SOFIE Biosciences Inc. (SOFIE) concludes $27.4m Series C Financing
Dulles, VA, November 4, 2020 - SOFIE, whose vision is to improve patient outcomes by developing and delivering molecular [...]